Author:
Kriegel Christina,Festag Matthias,Kishore Ravuri S.K.,Roethlisberger Dieter,Schmitt Georg
Abstract
Polysorbates 20 and 80 are the most frequently used excipients in biotherapeutics, the safety data for which have been well documented in adults. The polysorbate content in therapeutic formulations that are administered to children, however, has been less clearly regulated or defined with regard to safety. In pediatric patients, excessive amounts of polysorbate in biotherapeutics have been linked to hypersensitivity and other toxicity-related effects. To determine safe levels of polysorbates for young patients, we have developed the progressive pediatric safety factor (PPSF), an age- and weight-based tool that estimates the amount of parenterally administered polysorbates 20 and 80 in formulations that will avoid excipient-related adverse events. Compared with existing modalities for calculating maximum acceptable doses of excipients for initial clinical trials in pediatrics, the PPSF is far more conservative, thus constituting an added margin of safety for excipient exposure in the most sensitive subpopulations—i.e., neonates and infants. Further, the PPSF may be applied to any relevant excipient, aiding pharmaceutical developers and regulatory authorities in conservatively estimating the safety assessment of a biotherapeutic’s formulation, based on excipient levels.
Subject
Pediatrics, Perinatology and Child Health
Reference61 articles.
1. Considerations for the Use of Polysorbates in Biopharmaceuticals
2. Information for the Package Leaflet Regarding Polysorbates Used as Excipients in Medicinal Products for Human Use,2018
3. Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice;van Tellingen;Clin. Cancer Res.,1999
4. 1 Final Report on the Safety Assessment of Polysorbates 20, 21, 40, 60, 61, 65, 80, 81, and 85
5. Human Variability and Noncancer Risk Assessment—An Analysis of the Default Uncertainty Factor;Renwick;Regul. Toxicol. Pharmacol.,1998
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献